Global Burden of Disease, Injuries and Risk Factors Study 2010 -Preliminary Result Estimates- Janet L. Leasher, OD, MPH, FAAO On behalf of the GBD Vision.

Slides:

Advertisements

Similar presentations

HIV/AIDS Weakens the Immune System

Advertisements

No Goals at Half-time: What Next for the Millennium Development Goals? Goal 6: Combating HIV/AIDS, malaria and other diseases John Porter.

UNIVERSAL EYE HEALTH Ha Noi – Viet Nam 27 June 2014.

Ending AIDS by 2030 World AIDS Day Commemoration Addis Ababa, Ethiopia, 25 November 2014.

1 Global AIDS Epidemic The first AIDS case was diagnosed in years later, 20 million people are dead and 37.8 million people (range: 34.6–42.3 million)

Blood and Airborne Pathogens HIV/AIDS/STDs/HepatitisTB/SARS/Influenza.

00003-E-1 – December 2004 Global summary of the HIV and AIDS epidemic, December 2004 The ranges around the estimates in this table define the boundaries.

00002-E-1 – 1 December 2003 Global summary of the HIV/AIDS epidemic, December 2003 The ranges around the estimates in this table define the boundaries.

International Diabetes Federation

International Diabetes Federation

Peterson-Kaiser Health System Tracker What do we know about the burden of disease in the U.S.?

UNAIDS World AIDS Day Report | 2011 Core Epidemiology Slides.

Morbidity and Mortality Marcela Frazier OD,MPH, FAAO.

1 July 2008 e Global summary of the AIDS epidemic, December 2007 Total33 million [30 – 36 million] Adults30.8 million [28.2 – 34.0 million] Women15.5 million.

Course 10 Global Burden of Disease: Impact of Vision Loss Contribution of the GBD and dissemination of results Serge Resnikoff MD, PhD On behalf of the.

IAPB and VISION 2020 VISION 2020 UK AGM September 2013 Peter Ackland, CEO.

It is estimated that over 50 per cent of the African population do not have access to modern health facilities and more than 60 per cent of people in rural.

© 2006 Population Reference Bureau DEMOGRAPHY Demography = the statistical study of population *these stats are used for forming public policy and marketing.

Population-based impact of ART in high HIV prevalence settings Marie-Louise Newell Professor of Global Health Faculty of Medicine, Faculty of Social and.

AIDS in Sub Saharan Africa AIDS – a virus with no known cure first identified in the Belgian Congo in It’s now a global epidemic, and poverty and.

THE IMPACT OF AIDS ON OUR CONTINENT An overview. Global estimates for adults and children, end 2002.

Ayesha Abdullah By the end of this lecture the students should be able to: Define blindness, visual impairment & low vision according.

Incidence Hepatocellular Carcinoma is one of the most common malignancies worldwide More common in Asia and Africa than in the United States. The highest.

July 2015 Core Epidemiology Slides.

© 2007 Population Reference Bureau Map of HIV Prevalence Worldwide 2005 Source: UNAIDS, 2006 Report on the Global AIDS Epidemic, Adults Ages

00002-E-1 – 1 December 2001 Global summary of the HIV/AIDS epidemic, December 2001 Number of people living with HIV/AIDS Total40 million Adults37.2 million.

1 Total 33.2 million [30.6 – 36.1 million] Adults 30.8 million [28.2 – 33.6 million] Women 15.4 million [13.9 – 16.6 million] Children under 15 years 2.5.

00002-E-1 – 1 December 2002 Global summary of the HIV/AIDS epidemic, December 2002 Number of people living with HIV/AIDS Total42 million Adults38.6 million.

Health Statistics and Informatics Non-communicable diseases A global overview.

Source: WHO Global Burden of Disease Report Update 2004, Geneva 2008 Global Burden of Disease: chronic NCD responsible for high rates of premature mortality.

SKIN CANCER PREVENTION May Skin Cancer in Saskatchewan & Canada PART TWO.

Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Visual Impairment and Blindness in US Adults Varma R, Vajaranant TS, Burkemper.

Lesson 33 & 34 – pages  To learn that the structure of a countries population can be shown using a population pyramid.  To learn the population.

Closer to home “…older farmers, faced with financial difficulties, hint that the only way out may be to commit suicide so that their families can receive.

1 July 2008 e Global summary of the AIDS epidemic, December 2007 Total33 million [30 – 36 million] Adults30.8 million [28.2 – 34.0 million] Women15.5 million.

Core Epidemiology Slides

Global summary of the HIV and AIDS epidemic, December 2003

وضعیت HIV/AIDS در جهان و ايران

Regional HIV and AIDS statistics and features, 2006

US Burden of Disease and Injury Study, 1996

Global summary of the AIDS epidemic, December 2007

Overview of Global HIV Epidemic

Global summary of the HIV/AIDS epidemic, December 2003

Global summary of the AIDS epidemic, 2008

Global summary of the HIV/AIDS epidemic, December 2003

Estimated number of new HIV infections in young people

Global summary of the AIDS epidemic, 2008

What am I a map to show? LIFE EXPECTANCY. New Doc (Pop’n in Trans) Title: Patterns and Trends in Births and Mortality.

Regional HIV and AIDS statistics and features, 2003 and 2005

Global summary of the HIV and AIDS epidemic, December 2004

Key Issues Where is the world population distributed? Why is global population increasing? Why does population growth vary among regions? Why do some regions.

کلیات آموزش ایدز به زبان ساده

Estimated number of people living with HIV and adult HIV prevalence

Estimated adult and child deaths from AIDS  2009

Global burden of hypertension in the adult population

Global summary of the AIDS epidemic, December 2007

Global summary of the HIV/AIDS epidemic, December 2003

Causes of vision loss worldwide, 1990–2010: a systematic analysis

2007 World Population Data Sheet

survey prevalence (%) (year)

Global summary of the HIV and AIDS epidemic, 2005

Regional HIV and AIDS statistics 2008 and 2001

Global Summary of the HIV and AIDS Epidemic December 2004

Estimated number of people living with HIV and adult HIV prevalence

Children (<15 years) estimated to be living with HIV as of end 2005

Regional HIV and AIDS statistics and features for women, 2004 and 2006

Regional HIV and AIDS statistics and features, end of 2004

Global summary of the HIV and AIDS epidemic, 2005

Core epidemiology slides

July 2018 Core epidemiology slides.

Presentation transcript:

Global Burden of Disease, Injuries and Risk Factors Study Preliminary Result Estimates- Janet L. Leasher, OD, MPH, FAAO On behalf of the GBD Vision Loss Expert Group

Regional and Temporal Data Availability Plot Bourne R, Price H, Stevens G. Global Burden of Visual Impairment and Blindness. Arch Ophthalmol. 130:5; May 2012:

Bourne R, Price H, Stevens G. Global Burden of Visual Impairment and Blindness. Arch Ophthalmol. 130:5; May 2012: Data Availability Map

GBD Super Regions

Preliminary GBD Expert Group Estimates of Global Number of Persons in 2010 with Blind and Visual Impairment: 33.5 million Blind 199 million MSVI ( ) ( )

Trends The prevalence of blindness and MSVI has decreased in the last 20 years, despite the relative increase in older adults in the world population However, due to population growth, the estimates suggest that absolute blind population has been stable and the population with MSVI has increased.

GBD Blindness Estimates Age-standardized and Total Crude Number Age-stand.ardized Prev.alence Estimated Number blind

Ratio of Blindness to Moderate and Severe Visual Impairment Temporal Trends

Change in Blindness Prevalence from 1990 to 2010 by World Region

Change in Prevalence of Visual Impairment from by Global Region

Country Specific Information

Males Females Poland

Ratio of female-to-male prevalence

Summary Statistics Prelim. estimates 33.5 million people Blind in 2010 (29.6,38.1), 60.6% of Blind were female 199 million (177,231) had Moderate and Severe Visual Impairment in 2010, 56.8% female The highest age-standardized prevalence of blindness in those ≥ 50 years was in Western Sub- Saharan Africa at 5.8% The highest age-standardized prevalence of MSVI in those ≥ 50 years was in South Asia at 24.1%

Summary Trends The global age-standardized prevalence of blindness for adults aged 50+ years decreased from 3.1% (2.7%-3.6%) worldwide in 1990 to 2.0% (1.8%-2.3%) in The global age-standardized prevalence of MSVI for adults aged 50+ years decreased from 14.2% (11.2%-16.1%) worldwide in 1990 to 10.8% (9.7%-12.4%) in 2010.

Thank you all